These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1109 related items for PubMed ID: 22321072

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
    Kuhns MC, Kleinman SH, McNamara AL, Rawal B, Glynn S, Busch MP, REDS Study Group.
    Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Occult hepatitis B virus infection.
    Allain JP.
    Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
    [Abstract] [Full Text] [Related]

  • 5. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?
    Stramer SL, Zou S, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY.
    Transfusion; 2012 Feb; 52(2):440-6. PubMed ID: 21810101
    [Abstract] [Full Text] [Related]

  • 6. Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen-negative) infection in the acute stage.
    Yoshikawa A, Gotanda Y, Minegishi K, Taira R, Hino S, Tadokoro K, Ohnuma H, Miyakawa K, Tachibana K, Mizoguchi H, Japanese Red Cross NAT Screening Research Group.
    Transfusion; 2007 Jul; 47(7):1162-71. PubMed ID: 17581150
    [Abstract] [Full Text] [Related]

  • 7. Two HBV DNA+/HBsAg- blood donors identified by HBV NAT in Shenzhen, China.
    Shang G, Yan Y, Yang B, Shao C, Wang F, Li Q, Seed CR.
    Transfus Apher Sci; 2009 Aug; 41(1):3-7. PubMed ID: 19487161
    [Abstract] [Full Text] [Related]

  • 8. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection.
    Kiely P, Margaritis AR, Seed CR, Yang H, Australian Red Cross Blood Service NAT Study Group.
    Transfusion; 2014 Aug; 54(8):2084-91. PubMed ID: 24650170
    [Abstract] [Full Text] [Related]

  • 9. Sensitivity of hepatitis B virus DNA transcription-mediated amplification testing in hepatitis B surface antigen-positive blood donations.
    Bouchardeau F, Girault A, Razer A, Servant-Delmas A, Mercier M, Laperche S.
    Transfusion; 2006 Dec; 46(12):2047-52. PubMed ID: 17176315
    [Abstract] [Full Text] [Related]

  • 10. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test.
    Kleinman SH, Strong DM, Tegtmeier GG, Holland PV, Gorlin JB, Cousins C, Chiacchierini RP, Pietrelli LA.
    Transfusion; 2005 Aug; 45(8):1247-57. PubMed ID: 16078909
    [Abstract] [Full Text] [Related]

  • 11. Detection of an acute asymptomatic HBsAg negative hepatitis B virus infection in a blood donor by HBV DNA testing.
    Weber B, Mühlbacher A, Melchior W.
    J Clin Virol; 2005 Jan; 32(1):67-70. PubMed ID: 15572009
    [Abstract] [Full Text] [Related]

  • 12. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M, Lelie N, Sykes W, Crookes R, Swanevelder J, Gaggia L, Le Roux M, Kuun E, Gulube S, Reddy R.
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [Abstract] [Full Text] [Related]

  • 13. PRISM hepatitis B surface antigen detection of hepatits B virus minipool nucleic acid testing yield samples.
    Linauts S, Saldanha J, Strong DM.
    Transfusion; 2008 Jul; 48(7):1376-82. PubMed ID: 18422847
    [Abstract] [Full Text] [Related]

  • 14. Occult hepatitis B virus infection: implications in transfusion.
    Allain JP.
    Vox Sang; 2004 Feb; 86(2):83-91. PubMed ID: 15023176
    [Abstract] [Full Text] [Related]

  • 15. An improved Abbott ARCHITECT assay for the detection of hepatitis B virus surface antigen (HBsAg).
    Lou SC, Pearce SK, Lukaszewska TX, Taylor RE, Williams GT, Leary TP.
    J Clin Virol; 2011 May; 51(1):59-63. PubMed ID: 21367654
    [Abstract] [Full Text] [Related]

  • 16. Characterization of HBV DNA+/HBsAg- blood donors in Poland identified by triplex NAT.
    Brojer E, Grabarczyk P, Liszewski G, Mikulska M, Allain JP, Letowska M, Polish Blood Transfusion Service Viral Study Group.
    Hepatology; 2006 Dec; 44(6):1666-74. PubMed ID: 17133474
    [Abstract] [Full Text] [Related]

  • 17. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection.
    Behzad-Behbahani A, Mafi-Nejad A, Tabei SZ, Lankarani KB, Torab A, Moaddeb A.
    Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866
    [Abstract] [Full Text] [Related]

  • 18. Sensitivity of two hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) nucleic acid test systems relative to hepatitis B surface antigen, anti-HCV, anti-HIV, and p24/anti-HIV combination assays in seroconversion panels.
    Assal A, Barlet V, Deschaseaux M, Dupont I, Gallian P, Guitton C, Morel P, van Drimmelen H, David B, Lelie N, De Micco P.
    Transfusion; 2009 Feb; 49(2):301-10. PubMed ID: 19389212
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain.
    González R, Torres P, Castro E, Barbolla L, Candotti D, Koppelman M, Zaaijer HL, Lelie N, Allain JP, Echevarría JM.
    Transfusion; 2010 Jan; 50(1):221-30. PubMed ID: 19682332
    [Abstract] [Full Text] [Related]

  • 20. Nucleic acid testing to detect HBV infection in blood donors.
    Stramer SL, Wend U, Candotti D, Foster GA, Hollinger FB, Dodd RY, Allain JP, Gerlich W.
    N Engl J Med; 2011 Jan 20; 364(3):236-47. PubMed ID: 21247314
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.